Factors enhancing intestinal adaptation after bowel compensation

Digestive Diseases

Volumn 21, Issue 3, 2003, Pages 228-236

  Botsios, D S ^a,b   Vasiliadis, K D ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Growth factors; Gut adaptation; Intestinal failure

Indexed keywords

EPIDERMAL GROWTH FACTOR; GLUCAGON LIKE PEPTIDE 2; GLUTAMINE; GROWTH FACTOR; HUMAN GROWTH HORMONE; INTERLEUKIN 11; INTESTINE ENZYME; KERATINOCYTE GROWTH FACTOR; NEUROTENSIN; PROGLUCAGON; RECOMBINANT GROWTH FACTOR; RECOMBINANT GROWTH HORMONE; RECOMBINANT INTERLEUKIN 11; RECOMBINANT KERATINOCYTE GROWTH FACTOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; SHORT CHAIN FATTY ACID; SOMATOMEDIN A; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

CELL HYPERPLASIA; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; ENTERIC FEEDING; ENTEROPATHY; HUMAN; IMMUNOMODULATION; INTESTINE ADAPTATION; INTESTINE BRUSH BORDER; INTESTINE CELL; INTESTINE FUNCTION; INTESTINE SECRETION; INTESTINE TRANSIT TIME; INTESTINE VILLUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; SMALL INTESTINE ABSORPTION; TOTAL PARENTERAL NUTRITION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; APOPTOSIS; GROWTH SUBSTANCES; HUMANS; INTESTINAL ABSORPTION; INTESTINES; SHORT BOWEL SYNDROME;

EID: 0142156612     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073340     Document Type: Review

References (119)

1. Fleming CR, Remington M: Intestinal failure. Clin Surg Int 1981;2:219.
2. Irving M: Intestinal failure. J Gastroenterol Hepatol 2000;15:G26-G29.
3. Wilmore DW: Factor correlating with a successful outcome following extensive intestinal resection in newborn infants. J Pediatr 1972;80:88-95.
4. Okada A: Signaling factors for gut adaptation. Nestle Nutr Workshop Ser Clin Perform Programme 2002;7:169-178, discussion 178-181.
5. Jeppesen PB, Mortensen PB: Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut 2000;46:701.
6. Al-Nafussi Al, Wright NA: The effect of epidermal growth factor on cell proliferation of the gastrointestinal mucosa in rodents. Virchows Arch B Cell Pathol 1982;40:63-69.
7. Goodlad RA, Wilson TJG, Lenton W et al: Urogastrone-epidermal growth factor is trophic to the epithelium of parenterally fed rats. Experientia 1985;41:1161-163.
8. Oka Y, Ghishan FK, Greene HL et al: Effect of mouse epidermal growth factor/urogastrone on the functional maturation of rat intestine. Endocrinology 1983;112:940-944.
9. Thomson JS, Saxena SK, Greaton C et al: The effect of the route of delivery of urogastrone on intestinal regeneration. Surgery 1989;106:45-51.
10. Tsujikawa T, Bamba T, Hosada S: The trophic effect of epidermal growth factor on morphological changes and polyamine metabolism in the small intestine of rats. Gastroenterol Jpn 1990;25:328-334.
11. Ulshen MH, Lyn-Cook LE, Raasch RH: Effects of intraluminal epidermal growth factor on mucosal proliferation in the small intestine of adults rats. Gastroenterology 1986;91:1134-1140.
12. Dowling RH, Booth CC: Structural and functional changes following small intestinal resection in the rat. Clin Sci 1967;32:139-149.
13. Hanson WR: Proliferation and morphological adaptation of the intestine to experimental resection. Scand J Gastroenterol 1982;17:11-20.
14. Booth CC, Evans KT, Menzies T et al: Intestinal hypertrophy following partial resection of the small bowel in the rat. Br J Surg 1959;46:403-410.
15. Goodlad RA, Savage AP, Lenton W et al: Does resection enhance the response of the intestine to urogastrone-epidermal growth factor in the rat? Clin Sci 1988;75:121-126.
16. Schwartz MZ, Storazuk RB: Influence of epidermal growth factor on intestinal function in the rat: Comparison of systemic infusion versus luminal perfusion. Am J Surg 1988;155:18-22.
17. Goodlad RA, Raja KB, Peters TJ et al: Effects of urogastrone-epidermal growth factor on intestinal brush border enzymes and mitotic activity. Gut 1991;32:994-998.
18. Goodlad RA, Wilson TJG, Lenton W et al: Intravenous but not intragastric urogastrone-EGF to the intestine of parenterally fed rats. Gut 1987;28:573-582.
19. Chaet MS, Arya G, Ziegler MM, Warner BW: Epidermal growth factor enhances intestinal adaptation after massive small bowel resection. J Pediatr Surg 1994;29:1035-1039.
20. Thompson JS, Saxena SK, Sharp JG: Effect of the duration of infusion of urogastrone on intestinal regeneration in rabbits. Cell Tissue Kinet 1989;22:303-309.
21. Thompson JS, Sharp JG, Saxena SK: Stimulation of neomucosal growth by systemic urogastrone. J Surg Res 1987;42:402-410.
22. Thomson JS: Epidermal growth factor and the short bowel syndrome. J Parenteral Enteral Nutr 1999;23:S113-S116.
23. Read LC, Ford WDA, Filsell OH et al: Is orally-derived epidermal growth factor beneficial following premature birth or intestinal resection? Endocr Exp 1986;20:199-207.
24. Le Roith D: Insulin-like growth factors. Mass Med Soc 1997;336:633-639.
25. Lemmey AB, Matine AA, Read LC et al: IGF-1 and the truncated analogue des-(1-3) IGF-1 enhance growth in rats after gut resection. Am J Physiol 1991;260:E213-E219.
26. Steeb CB, Trahair JF, Tomas FM et al: Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am J Physiol 1993;266:G1090-G1098.
27. Chen K, Inoue M, Wasa M, Azuma T, Fukuzawa M, Kamata S, Okada A: Insulin-like growth factor-I stimulates intestinal epithelial cell proliferation and migration. Surg Forum 1997;48:716-718.
28. Sigalet DL, Martin GR: Hormonal therapy for short bowel syndrome. J Pediatr Surg 2000;35:360-364.
29. Williamson R: Intestinal adaptation: Structural, functional and cytokinetic changes. N Engl J Med 1978;298:144, 1393-1402, 1450.
30. Thomson JS: Can the intestine adapt to a changing environment? Gastroenterology 1997;113:1402-1412.
31. Derynck R: Transforming growth factor-α. Cell 1988;54:593.
32. Alison MR, Sarraf CE: The role of growth factors in intestinal cell proliferation. Cell Biol Int 1994;18:1.
33. Falcone RA, Stern LE, Kemp CJ, Erwin CR, Warner BW: Intestinal adaptation occurs independent of transforming growth factor-α. J Pediatr Surg 2000;35:365.
34. Delarco JE, Torado GJ: Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 1978;75:4001.
35. Malden LT, Novak U, Burgess AW: Expression of transforming growth factor-α messenger in the normal and neoplastic gastrointestinal tract. Int J Cancer 1989;43:380.
36. Hormi K, Lehy T: Transforming growth factor-α in vivo stimulates epithelial cell proliferation in digestive tissues of suckling rats. Gut 1996;39:532.
37. Barnard JA, Polk WH, Moses HL, Coffey RJ: Production of transforming growth factor-α by normal small intestine. Am J Physiol 1991;261:C994.
38. Konturek SJ, Brzozowski T, Maka J, Dembinski A, Slomiany A, Slomiany BL: Transforming growth factor-α and epidermal growth factor in protection and healing of gastric mucosal injury. Scand J Gastroenterol 1992;27:649.
39. Romano M, Polk WH, Awad JA, Arteaga CL, Nanney LB, Wargovich MJ, Kraus ER, Boland CR, Coffey RJ: Transforming growth factor-α protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest 1992;90:2409.
40. Dignass AU, Stow JL, Babyatsky MW: Acute epithelial injury in the rat small intestine in vivo is associated with expanded expression of transforming growth factor-α and β. Gut 1996;38:291.
41. Sukhotnik I, Yakirevich E, Coran AG, Siplovich L, Krausz M, Hirsh M, Sabo E, Shiloni E: Effect of transforming growth factor-α on intestinal adaptation in a rat model of short bowel syndrome. J Surg Res 2002;108:235-242.
42. Helmstaedter V, Taugner CH, Feurle GE, Forssmann WG: Localization of neurotensin-immunoreactive cells in the small intestine of man and various mammals. Histochemistry 1977;53:35-41.
43. Holst-Pedersen J, Fahrenkrug J: Neurotensin-like immunoreactivities in human plasma: Feeding responses and metabolism. Peptides 1986;7:15-20.
44. Thor K, Rosell S: Neurotensin increases colonic motility. Gastroenterology 1986;90:27-31.
45. 4]-neurotensin. Acta Physiol Scand 1977;100:231-235.
46. Harper SL, Barrowman JA, Kvietys PR, Granger DN: Effect of neurotensin on intestinal capillary permeability and blood flow. Am J Physiol 1984;247:G161-G166.
47. Mitchenere P, Adrian TE, Kirk RM, Bloom SR: Effect of gut regulatory peptides on intestinal luminal fluid in the rat. Life Sci 1981;29:1563-1570.
48. Wood JG, Hoang HD, Bussjaeger LJ, Solomon TE: Neurotensin stimulates growth of small intestine in rats. Am J Physiol 1988;255:813-817.
49. Folkers K, Chang D, Humphries J, Carraway R, Leeman SE, Bowers CY: Synthesis and activities of neurotensin and its acid and amine analogs: Possible natural occurrence of Gln4-neurotensin. Proc Natl Acad Sci USA 1976;73:3833-3837
50. Ukai M, Inoue I, Itatsu T: Effect of somatostatin on neurotensin-induced glucagon release and hyperglycemia. Endocrinology 1977;100:1284-1286.
51. Burke D, Alverdy J, Aoys E, Agarwal A, Moss G: The effect of neurotension and epidermal growth factor on TPN induced IgA deficiency. Surg Forum 1990;41:70-72.
52. Du XX, Williams DA: Interleukin-11: Review of molecular, cell biology and clinical use. Blood 1997;89:3897-3908.
53. Du XX, Williams DA: Interleukin-11: A multi-functional growth factor derived from the hematopoietic microenvironment. Blood 1994;83:2023-2030.
54. Du XX, Neben T, Goldman S: Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: Acceleration of recovery of peripheral blood neutrophils and platelets. Blood 1993;81:27-34.
55. Schindel D, Maze R, Liu, Q et al: Interleukin-11 improves survival and reduces bacterial translocation and bone marrow suppression inburned mice. J Pediatr Surg 1997;32:312-315.
56. Liu Q, Du XX, Schindel DT et al: Trophic effects of interleukin-11 in rats with experimental short bowel syndrome. J Pediatr Surg 1996;31:1047-1051.
57. Fiore NF, Ledniczky G, Liu Q et al: Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection. J Pediatr Surg 1998;33:24-29.
58. Alavi K, Prasad R, Lundgren K, Schwartz MZ: Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinalad aptation. J Pediatr Surg 2000;35:371-374.
59. Prasad R, Alavi K, Schwartz MZ: Glucagon-like peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion. J Pediatr Surg 2000;35:357-359.
60. Gleeson MH, Bloom SR, Polak JM et al: Endocrine tumour in kidney affecting small bowel structure, motility and absorptive function. Gut 1971;12:773-782.
61. Stevens FM, Flanagan RW, O'Gorman D et al: Glucagonoma syndrome demonstrating giant duodenal villi. Gut 1984;25:784-791.
62. Drucker DJ, Ehrlich P, Asa SL et al: Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 1996;93:7911-7916.
63. Brubaker PL, Izzo A, Hill M et al: Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol 1997;272:E1050-E1058.
64. Tsai C, Hill M, Asa SL et al: Intestinal growth promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 1997;273:E77-E84.
65. Fischer KD, Dhanvantari S, Drucker DJ et al:Intestinal growth is associated with elevated levels of glucagon-like peptide-2 in diabetic rats. Am J Physiol 1997;273:E815-E820.
66. 2] glucagon-like peptide 2. Am J Physiol 1997;273:G1252-G1262.
67. Kato Y, Alavi K, Yu D et al: Glucagon-likepeptide-2 enhances intestinal function following massive small bowel resection. Gastroenterology 1998;114:A1152.
68. Aaronson SA, Bottaro DP, Miki T, Ron D, Finch PW, Fleming TP et al: Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann NY Acad Sci 1991;638:62-77.
69. Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE et al: Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994;94:1764-1777.
70. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT: Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 1992;89:6896-6900.
71. Staiano-Coico L, Krueger JG, Rubin JS, D'limi S, Vallat VP, Valentino L et al: Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med 1993;178:865-878.
72. Brauchle M, Madlener M, Wagner AD, Angermeyer K, Lauer U, Hofschneider PH et al: Keratinocyte growth factor is highly over expressed in inflammatory bowel disease. Am J Pathol 1996;149:521-529.
73. Finch PW, Pricolo V, Wu A, Finkelstein SD: Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology 1996;110:441-451.
74. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989;245:752-755.
75. Zeeh JM, Proccacino F, Hoffmann P, Aukerman SL, McRoberts JA, Soltani S et al: Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 1996;110:1077-1083.
76. Egger B, Proccacino F, Sarosi I, Tolmos J, Büchler MW, Eysselein VE: Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice. Dig Dis Sci 1999;44:836-844.
77. Egger B, Tolmos J, Proccacino F, Sarosi I, Friess H, Büchler MW et al: Keratinocyte growth factor promotes healing of left sided colon anastomoses. Am J Surg 1998;176:18-24.
78. Estivarez CF, Jonas CR, Gu LH, Diaz EE, Wallace TM, Pascal RR, Farrell CL, Ziegler TR: Gut-trophic effects of keratinocyte growth factor in rat small intestine and colon during enteral refeeding. J Parenter Enteral Nutr 1998;22:259-267.
79. Johnson WF, DiPalma CR, Ziegler TR, Scully S, Farrell CL: Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome. Vet Surg 2000;29:17-27.
80. Yang H, Wildhaber BE, Teitelbaum DH: Harry M. Vars Research Award: Keratinocyte growth factor improves epithelial function after massive small bowel resection. J Parenter Enteral Nutr 2003;27:198-206.
81. Wilmore DW, Moylan JA Jr, Bristow BF, Mason AD Jr, Pruitt BA Jr: Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 1974;138:875-884.
82. Mainoya JR: Influence of ovine growth hormone on water and NaCl absorption by the rat proximal jejunum and distal ileum. Comp Biochem Physiol 1982;71A:477-479.
83. Byrne TA, Persinger RL, Young LS et al: A new treatment for patients with short bowel syndrome. Ann Surg 1995;222:243-255.
84. Scolapio JS, Calilleri M, Gleming CR et al: Effect of growth hormone, glutamine and diet on adaptation in short bowel syndrome: A randomized, controlled study. Gastroenterology 1997;113:1074-1081.
85. Park JHY, Vanderhoof JA: Growth hormone did not enhance mucosal hyperplasia after small bowel resection. Scand J Gastroenterol 1996;31:349-354.
86. Vanderhoof JA, Kollmann KA, Griffin S et al: Growth hormone and glutamine do not stimulate intestinal adaptation following massive small bowel resection in the rat. J Pediatr Gastroenterol Nutr 1997;25:327-331.
87. Shulman DI, Hu CS, Duckett G et al: Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol Nutr 1992;14:3-11.
88. Benhamou PH, Canarelli JP, Richard C et al: Human recombinant growth hormone increases small bowel lengthening after massive small bowel resection in piglets. J Pediatr Surg 1997;32:1332-1336.
89. Kissmeyer-Nielsen P, Jensen MB, Laurberg S: Perioperative growth hormone treatment and functional outcome after major abdominal surgery. A randomized double-blind, controlled study. Ann Surg 1999;229:298-302.
90. Gomez de Segura IA, Aguilera MJ, Codesal J, De Miguel E: Administration of growth hormone enhances the intestinal adaptive response after resection of small intestine in rats. Rev Esp Enferm Dig 1995;87:288-293.
91. Cummings MC, Winterford CM, Walker NI: Apoptosis. Am J Surg Pathol 1997;21:88-101.
92. Cummings JH: Colonic absorption: The importance of short chain fatty acids in man. Scand J Gastroenterol 1984;19(suppl 93):89-99.
93. Koruda MJ, Rolandeli RH, Bliss DZ, Hastings J, Rombeau JL, Settle RG: Parenteral nutrition supplemented with short-chain fatty acids: Effects on the small-bowel mucosa in normal rats. Am J Clin Nutr 1990;51:685-689.
94. Koruda MJ, Rolandeli RH, Settle RG, Zimmaro DM, Rombeau JL: Effect of parenteral nutrition supplemented with short chain fatty acids on adaptation to massive small bowel resection. Gastroenterology 1988;95:715-720.
95. Tappenden KA, Thomson ABR, Wild GE, McBurney MI: Short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs following intestinal resection in rats. J Parenter Enteral Nutr 1996;20:357-362.
96. Tappenden KA, Thomson ABR, Wild GE, McBurney MI: Short-chain fatty acid supplemented total parenteral nutrition enhances intestinal function following massive small bowel resection. Gastroenterology 1997;112:792-802.
97. Bloom SR, Polak JM: The hormonal pattern of intestinal adaptation: A major role for enteroglucagon. Scand J Gastroenterol Suppl 1982;14:93-103.
98. Sagor GR, Ghatei MA, Al-Mukhtar MYT, Wright NA, Bloom SR: Evidence for a humoral mechanism after small intestinal resection: exclusion of gastrin but not enteroglucagon. Gastroenterology 1983;84:902-906.
99. Rountree DB, Ulshen MH, Selub S et al: Nutrient independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection. Gastroenterology 1992;103:462-468.
100. Taylor RG, Verity K, Fuller PJ: Ileal glucagongene expression: Ontogeny and response to massive small bowel resection. Gastroenterology 1990;99:724-729.
101. Cheeseman CI, Tsang R: The effect of gastric inhibitory polypeptide and glucagons like peptides on intestinal hexose transport. Am J Physiol 1996;261:G477-G482.
102. Dowling RH: Small bowel resection and its regulation. Scand J Gastroenterol Suppl 1982;17:53-74.
103. Gornacz GE, Al-Mukhtar MYT, Ghatei MA, Sagor GR, Wright NA, Bloom SR: Pattern of cell proliferation and enteroglucagon response following small bowel resection in the rat. Digestion 1984;29:65-72.
104. Al-Mukhtar MYT, Sagor GR, Ghati MA, Bloom SR, Wright NA: The role of pancreatico-biliary secretions in intestinal adaptation after resection, and its relationship to plasma enteroglucagon. Br J Surg 1983;70:398-400.
105. Tappenden KA, Drozdowski LA, Thomson AB, McBarney MI: Short-chain fatty acid supplemented total parenteral nutrition alters intestinal structure, glucose transporter-2 mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr 1998;68:118-125.
106. Souba WW: Intestinal glutamine metabolism and nutrition. J Nutr Biochem 1993;4:2-9.
107. Winmueller HG, Spaeth AE: Identification of ketone bodies and glutamine as the major respiratory fuel in vivo for post-absorptive rat small intestine. J Biol Chem 1978;1078:69-76.
108. Wiren M, Permert J, Skullman S, Wang F, Larsson J: Intraluminal glutamine refeeding supports mucosal growth in rat jejunum. Transplant Proc 1994;26:1460-1463.
109. Barber AE, Jones WG, Minei JP et al: Glutamine or fiber supplementation of a defined formula diet: Impact on bacterial translocation, tissue composition and response to endotoxin. J Parenter Enteral Nutr 1990;14:335-343.
110. Wiren M, Magnusson KE, Larsson J: Enteralglutamine increases growth and absorptive capacity of intestinal mucosa in the malnourished rat. Scand J Gastroenterol 1995;30:146-152.
111. Tamada H, Nezu R, Imamura I, Takagi Y, Okada A: The dipeptide alanyl glutamine prevents intestinal mucosal atrophy in parenterally fed rats. J Parenter Enteral Nutr 1992;16:110-116.
112. Tamada H, Nezu R, Matsuo Y, Imamura I, Takagi Y, Okada A: Alanyl glutamine-enriched total parenteral nutrition restores intestinal adaptation after either proximal or distal massive resection in rats. J Parenter Enteral Nutr 1993;17:236-242.
113. Khan J, Liboshi Y, Cui L, Wasa M, Sando K, Takagi Y, Okada A: Alanyl-glutamine-supplemented parenteral nutrition increases luminal mucus gel and decreases permeability in the rat small intestine. J Parenter Enteral Nutr 1999;23:24-31.
114. Ziegler TR, Young LS, Banfell K, Shelings M, Hortos K, Bye R, Morrow FD, Jacobs DO, Smith RJ, Antin JH, Wilmore DD: Clinical and metabolic efficiency of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized doubleblind, control study. Ann Intern Med 1992;116:821-828.
115. Mochizuki H, Saito H, Tashiro T, Tahara Y, Okada A: A clinical study on the effect of alanyl-glutamine supplemented TPN in gastrectomized patients - Early II study (abstract). J Parenter Enteral Nutr 1999;23(suppl):160.
116. Griffiths RD, Jones C, Palmer A: A six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997;13:295-302.
117. Wilmore DW, Lacey JM, Soultanakis RP, Bosch RL, Burne TA: Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997;226:288-292.
118. Mandir N, Goodlad RA: The effects of glutamine on intestinal cell proliferation in parenterally fed rats. Gut 1999;44:608-614.
119. Alavi K, Kato Y, Yu D, Schwartz MZ: Enteral glutamine does not enhance the effects of hepatocyte growth factor in short bowel syndrome. J Pediatr Surg 1998;33:1666-1669.